Acurx PharmaceuticalsACXP
13F holders, Q2 2024 (June 30)25holders −1
4new positions
4sold out
1famous investor
$2.24avg. 13F price*
At the end of Q2 2024, 25 institutions reported holding Acurx Pharmaceuticals Inc. (ACXP) in their 13F filings, down 1 from Q1 2024. 4 opened new positions and 4 sold out. The largest holders were Vanguard Group Inc. ($1.1M), Prospect Financial Services LLC ($626K) and Geode Capital Management, LLC ($293K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Acurx Pharmaceuticals Inc.
- CUSIP
- 00510M104
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $6K |
| Exits | 4 | $156K |
All 13F filers, Q1 2024 → Q2 2024: 80,412 shares bought and 121,662 shares sold, net −41,250 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 25 holders
| Vanguard Group Inc. | 0.00% | No change | 491,687 | $1.1M |
| Prospect Financial Services LLC | 0.48% | Add +1.9% | 278,100 | $626K |
| Geode Capital Management, LLC | 0.00% | Add +11.7% | 130,015 | $293K |
| LPL Financial LLC | 0.00% | Add +33.5% | 53,735 | $121K |
| Morgan Stanley | 0.00% | Add +75.8% | 46,401 | $104K |
| State Street Corp. | 0.00% | No change | 43,466 | $98K |
| BlackRock Inc. | 0.00% | Add +47.2% | 27,503 | $62K |
| Northern Trust Corp. | 0.00% | Add +59.1% | 27,286 | $61K |
| Lanark Financial, Inc. | 0.00% | Add +35.7% | 19,000 | $42K |
| TD Waterhouse Canada Inc. | 0.00% | No change | 18,656 | $40K |
| Osaic Holdings, Inc. | 0.00% | Reduce -73.4% | 15,210 | $34K |
| Patriot Financial Group Insurance Agency, LLC | 0.00% | No change | 10,385 | $23K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | No change | 10,000 | $23K |
| Tocqueville Asset Management L.P. | 0.00% | No change | 10,000 | $23K |
| Group One Trading LLC | 0.00% | Reduce -61.3% | 5,222 | $12K |
| Semmax Financial Advisors Inc. | 0.00% | No change | 5,879 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +44.3% | 4,138 | $9K |
| Cornerstone Planning Group LLC | 0.00% | No change | 3,344 | $6K |
| Simplex Trading, LLC | 0.00% | Reduce -72.8% | 2,918 | $6K |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 1,636 | $4K |
| UBS Group AG | 0.00% | New | 881 | $2K |
| GPS Wealth Strategies Group, LLC | 0.00% | No change | 500 | $1K |
| Bank of America Corp. | 0.00% | New | 105 | $236 |
| Citadel Advisors | 0.00% | New | 64 | $144 |
| Royal Bank of Canada | 0.00% | Add +256.8% | 132 | $0 |
"% of holder's portfolio" is ACXP's weight in each manager's 13F, not the share of Acurx Pharmaceuticals Inc. the manager owns.